Characterization of a new form of inherited hypercholesterolemia: Familial recessive hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 802-809

  Zuliani, G ^a   Arca, M ^b   Signore, A ^b   Bader, G ^a   Fazio, S ^c   Chianelli, M ^b   Bellosta, S ^d   Campagna, F ^b   Montali, A ^b   Maioli, M ^e   Pacifico, A ^e   Ricci, G ^b   Fellin, Renato ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

apoB; Genetics; Hypercholesterolemia; LDL receptor; LDL turnover

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHOLESTEROL ESTER STORAGE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; PRIORITY JOURNAL;

EID: 0033012287     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.802     Document Type: Article

References (37)

1. Grundy SM. Multifactorial etiology of hypercholesterolemia. Arterioscler Thromb. 1991;11:619-635.
2. Hobbs HH, Russell DW, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet. 1990;24:133-170.
3. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AI, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Diseases. New York, NY: McGraw-Hill; 1990:1215-1250.
4. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A. 1989; 86:587-591.
5. Bhattacharyya AK, Connor WE. β-Sitosterolemia and xanthomatosis: a newly described lipid storage disease in two sisters. J Clin Invest. 1973; 52:9a. Abstract.
6. Anderson RA, Byrum RS, Coates PM, Sando GN. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci U S A. 1994;91:1881-1883.
7. Zuliani G, Vigna GB, Corsini A, Maioli M, Romagnoni F, Fellin R. Severe hypercholesterolemia: unusual inheritance in Italian pedigree. Eur J Clin Invest. 1995;25:322-331.
8. Leren TP, Solberg K, Rodningen OK, Tonstad S, Ose L. Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis. 1994;111:175-182.
9. Brown MS, Sobhani MK, Brunschede GY, Goldstein JL. Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. J Biol Chem. 1976;251:3277-3286.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
11. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16:1215.
12. Lee JS. Alternative dideoxy sequencing of double-stranded DNA by cyclic reaction using Taq polymerase. DNA Cell Biol. 1991;10:67-73.
13. Area M, Vega GL, Grundy SM. Hypercholesterolemia in postmenopausal women: metabolic defects and response to low-dose lovastatin. JAMA. 1994;271:453-459.
14. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren RT, Aamodt RL, Brewer HB. Human apolipoprotein A-I and A-II metabolism. J Lipid Res. 1982;23:850-862.
15. McFarlane AS. Efficient trace-labeling of patients with iodine. Nature. 1958;182:53.
16. Berman M, Weiss F. SAAM Manual. Washington DC: Dept of Health, Education and Welfare; 1978. NIH publication No. 78-180.
17. Matthews CME. The theory of tracer experiments with iodine 131-labeled plasma proteins. Phys Med Biol. 1957;2:36-53.
18. Iuliano L, Signore A, Vallabhaiosula S, Colavita AR, Camastra C, Ronga G, Alessandri C, Sbarigia E, Fiorani P, Violi F. Preparation and biodistribution of 99m-Technetium labelled oxidized LDL in man. Atherosclerosis. 1996;20:180-192.
19. Roeschlau P, Bernt E, Gruber W. Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem. 1974;12:226-227.
20. McGowan MW, Artis JD, Strandberg DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983;29:538-542.
21. Albers J, Warnick GR, Chung MC. Quantitation of high density lipoproteins. Lipids. 1978;12:926-932.
22. Sando GN, Rosenbaum LM. Human lysosomal acid lipase cholesteryl ester hydrolase: purification and properties of the form secreted by fibroblasts in microcarrier culture. J Biol Chem. 1985;260:15186-15193.
23. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31: 545-548.
24. Yokode M, Pathak RK, Hammer RE, Brown MS, Goldstein JL, Anderson RGW. Cytoplasmic sequence required for basolateral targeting of LDL receptor in livers of transgenic mice. J Cell Biol. 1992;117:39-46.
25. Assmann G, Fredrickson DS. Acid lipase deficiency: Wolman's disease and cholesteryl ester storage disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The Metabolic Basis of Inherited Diseases. New York, NY: McGraw-Hill; 1983:803-819.
26. Vega GL, Hobbs HH, Grundy SM. Low density lipoprotein kinetics in a family having defective low density lipoprotein receptor in which hypercholesterolemia is suppressed. Arterioscler Thromb. 1991;11:578-585.
27. Morganroth J, Levy RI, McMahon AE, Gotto AM. Pseudohomozygous type II hyperlipoproteinemia. J Pediatr. 1974;85:639-643.
28. Masana L, Joven J, Rubies-Prat J, Lewis B. Low density lipoprotein metabolism and receptor studies in a patient with pseudohomozygous familial hypercholesterolemia. Acta Pediatr Scand. 1990;79:475-476.
29. Sirtori CR, Catapano AL, Franceschini G, Corsini A, Noseda G, Frangiacomo C, Panzeri E, Vaccarino V, Guenzi S, Casari G. Aortic and coronary atheromatosis in a woman with severe hypercholesterolemia without LDL receptor alterations. Eur Heart J. 1991;12:818-824.
30. Harada-Shiba M, Tajima S, Yokoyama S, Miyake Y, Kojima S, Tsushima M, Kawakami M, Yamamoto A. Siblings with normal LDL receptor activity and severe hypercholesterolemia. Arterioscler Thromb. 1992;12: 1071-1078.
31. Vitol S, Angelin B, Ericsson S, Gahrton G, Juliusson G, Masquelier M, Paul C, Peterson C, Rudling M, Soderberg-Reid K, et al. Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci U S A. 1990;87:2598-2602.
32. Rudling M, Reihner E, Einarsson K, Ewerth S, Angelin B. Low density lipoprotein receptor-binding in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. Proc Natl Acad Sci U S A. 1990;97:3469-3473.
33. Vallabajosula S, Paidi' M, Badimon JJ, Le N-A, Goldsmith SJ, Fuster V, Ginsberg HN. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99 m low density lipoproteins versus radioiodinated low density lipoprotein preparation. J Nucl Med. 1988;29: 1237-1242.
34. Liscum L, Underwood KM. Intracellular cholesterol transport and compartmentation. J Biol Chem. 1995;270:15443-15446.
35. Wang W, Briggs MR, Hua X, Yokoyama C, Goldstein JL, Brown MS. Nuclear protein that binds sterol regulatory element of LDL receptor promoter, II: purification and characterization. J Biol Chem. 1993;268: 14497-14504.
36. Havekes LM, De Wit ECM, Princen HMG. Cellular free cholesterol in HepG2 cells is only partially available for down-regulation of low-density lipoprotein receptor activity. Biochem J. 1987;247:739-746.
37. Liscum L, Dahl NK. Intracellular cholesterol transport. J Lipid Res. 1992;10:1239-1254.